Prediction of 10-year distant recurrence (DR) using the Prosigna® (PAM50) test in a Danish Breast Cancer Cooperative Group (DBCG) cohort of postmenopausal Danish women with hormone receptor-positive (HR ) early breast c - substantial equivalence - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2016-03-18 04:49:43 Clinical medicine Cancer Medicine RTT Ribbon symbolism Breast cancer Adjuvant therapy Aromatase inhibitor Oncotype DX MammaPrint		Prediction of 10-year distant recurrence (DR) using the Prosigna® (PAM50) test in a Danish Breast Cancer Cooperative Group (DBCG) cohort of postmenopausal Danish women with hormone receptor-positive (HR+) early breast c Add to Reading List Source URL: www.dbcg.dk Download Document from Source Website File Size: 1,76 MB Share Document on Facebook

	Edorium J Disabil Rehabil 2015;1:9–11. www.edoriumjournals.com/ej/dr Letter to Editors Massoni et al. DocID: 1ru4d - View Document
	000 Kinect Based Method for the BCCT Quantitative 3D evaluationHélder P. Oliveira1 DocID: 1rovH - View Document
	Compare your diagnosis with a million others. PenProfiler. Does your Mammography Information System offer the newest dimension in diagnosis? DocID: 1rnF0 - View Document
	CAMPAIGN AT A GLANCE Breast Cancer Action takes on pinkwashers: corporations or organizations that peddle products linked to breast cancer while claiming to care about DocID: 1rnAP - View Document
	· METASTATIC BREAST CANCER · Assessing Treatment Response in Metastatic Breast Cancer Shlomit Strulov Shachar, MD, and Hyman B. Muss, MD Abstract DocID: 1rmV3 - View Document